Print this page

Inflammatory Bowel Disease Research

The Canterbury Inflammatory Bowel Disease Project

The Canterbury IBD Study is a population-based research project designed to investigate IBD epidemiology (frequency), aetiology (causes), clinical outcomes and treatments. Over 1400 IBD patients (comprising more than 92% of all people with IBD in Canterbury in 2005) were recruited into the study.  Each subject completed a questionnaire and gave blood samples for genetic and other analyses.  The research is continuing using the gathered clinical and environmental information, serum and DNA from this population.

Publications for the Project click here

Collaborators on the IBD Project:

The Gene Structure and Function Laboratory (University of Otago, Christchurch)       Nutrigenomics (Auckland)        Crohn's and Colitis Support Group

Gut Health Network

New Zealand IBD Clinical Trials Network

The listed units have established facilities for conducting clinical trials in inflammatory bowel disease and are currently participating in trials of new treatments in New Zealand.  It is possible that other units will join this network also.

Department of Gastroenterology and Hepatology
Auckland Hospital
Investigator:    Dr David Rowbotham Clinical Trial Coordinators Dee Yang

Contact:   Tel: +64 9 3074949 ext 25581   Fax: +64 9 3078984

Shakespeare Specialist Group
North Shore, Auckland
Investigator:  Dr Ian Wallace
Study Coordinator: Kathy Love
Contact:   Tel: +64 9 489 2384     Fax: +64 9 486 0189
Department of Gastroenterology
Wellington Hospital
Investigator:  Dr Ben Griffiths & Dr Rees Cameron
Research Nurse:Jonathan Barrett
Contact:04 9185136

Department of Gastroenterology
Christchurch Hospital
Investigator: Prof Richard Gearry Trial Manager:Katherine Denton
Coordinators/Research Nurses: Rhondda Brown and Tracy Noonan,
Contact:   Tel: +64 3 3640135     Fax: +64 3 3641624

Department of Gastroenterology
Waikato Hospital
Investigator:  Dr Frank Weilert
Clinical Trial Coordinators / Research Nurses: Chris Tuffery, Nancy Sullivan, Sherryl Hayett

Contact:  Tel:  +64 7 839 8899 ext 23017  Fax: +64 7 858 0984

Department of Gastroenterology and Hepatology
Middlemore Hospital
Investigator:      Dr Tien Huey Lim

Contact:   Tel: +64 9 2760044  ext 8749 
Department of Gastroenterology
Hawke's Bay Hospital
Investigator:  Dr Malcolm Arnold
Research Coordinator: Diana Schmid
Contact:  Tel:  +64 6 8788109 ext 6628  Fax: +64 6 8781328
Department of Gastroenterology
Dunedin Public Hospital
Investigator:  Dr Michael Schultz
Research Nurse: Aroha Bolton and Dawn France
Contact: Tel: +64 3 474 0009 ext. 58054    Fax: +64 3 470 9358

Advantages to conducting clinical trials in New Zealand include:

  • A single national ethics committee process with no cost attached.  The committee meets monthly.
  • A rapid regulatory approval process via the SCOTT committee, which acts under the auspices of the HRC.  SCOTT committee turnaround time is usually less than 4 weeks.
  • There are large numbers of patients with IBD in New Zealand, which has one of the highest incidence rates in the world.
  • New Zealand has limited access to new biological therapies in normal clinical practice.

Previous page: Research
Next page: Bowel Cancer Research